Menu
← Oncology Approval Tracker
FDA DECISION ·
Romidepsin injection
romidepsin · Amneal EU
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
First generic of the reference romidepsin injection for adults with cutaneous T-cell lymphoma after at least one prior systemic therapy.
LAMPGEN ANALYSIS
Why it matters
This approval concerns the listed injectable presentation for an established later-line use in cutaneous T-cell lymphoma.
What research teams should watch
Verify the selected formulation, preparation and sourcing before updating a pharmacy workflow. Track prior systemic therapy in clinical documentation.
PRIMARY RECORDS